Joint and muscle pain is the menopause symptom most women don't see coming. Hot flashes get the attention, but a 2024 meta-analysis of 321 studies found that joint and muscular discomfort had the highest pooled prevalence of any symptom assessed across the menopausal transition: 65.43% among middle-aged women, compared to 52.65% for hot flashes.
Red light therapy for menopause symptoms has become a growing area of research interest, and his article presents the science as it exists, with evidence quality identified for each category. For a broader look at how hormonal changes affect these systems, see our review of red light therapy for hormone health.
Key Takeaways
- Joint and muscle pain, the most prevalent symptom across the menopausal transition, has the strongest evidence base for red light therapy, supported by multiple meta-analyses of controlled clinical trials in osteoarthritis and musculoskeletal pain populations
- Red light therapy works by increasing cellular energy production and reducing inflammation, mechanisms documented at the cellular level and confirmed in clinical pain studies
- Red light therapy can help menopausal women deal with musculoskeletal pain, sleep issues, skin, and pelvic tissue health
What Is Menopause and Why Does It Matter?
Menopause marks the permanent end of a woman's menstrual cycles, formally defined as 12 consecutive months without a period. It typically arrives in the early 50s. The years of hormonal fluctuation leading up to it, called perimenopause, can stretch across a decade. During this window, declining estrogen and progesterone affect virtually every body system that depends on these hormones for regulation: joints, skin, the nervous system, sleep architecture, and the brain's emotional regulation pathways.
Conventional medicine typically addresses these symptoms in isolation. Sleep aids for insomnia. Antidepressants for mood. NSAIDs for joint pain. Hormone replacement therapy as a broader intervention. Each approach carries genuine benefits alongside real limitations. NSAIDs carry gastrointestinal and cardiovascular risks with long-term use. Hormone therapy is not appropriate for all women, and many prefer to avoid it. What has been missing is a single, non-invasive approach that addresses the cellular mechanisms driving multiple symptoms at once. Red light therapy for menopause symptoms is drawing attention because it doesn't work that way. It targets the cellular energy loss and chronic inflammation that drive these problems at their source.
How Red Light Therapy Works
Red light therapy delivers specific wavelengths of red (typically 630-660 nm) and near-infrared (typically 810-850 nm) light into body tissue. In clinical research, the process is called photobiomodulation, or PBM.
The core mechanism is established at the cellular level. When red or near-infrared light reaches the mitochondria (the energy-producing structures inside every cell), it activates a key enzyme and triggers a measurable increase in cellular energy output. Cells with more energy clear inflammatory signals more efficiently and maintain healthier function. This mechanism has been confirmed in cell culture, animal models, and clinical settings.
During menopause, falling estrogen levels activate inflammatory pathways that estrogen normally keeps in check, elevating the same proteins responsible for joint inflammation, swelling, and pain. A 2023 narrative review by Zhang, R. and Qu, J. examined how PBM reduces these inflammation signals in arthritis models across cell culture and animal studies. The inflammatory proteins involved overlap, and can therefore reduce inflammation in menopausal women. For more on PBM and inflammation, see our review of red light therapy for inflammation.
Evidence by Symptom
Joint and Muscle Pain
Multiple meta-analyses of placebo-controlled trials have examined PBM for musculoskeletal pain conditions highly prevalent during the menopausal transition. The populations studied were general osteoarthritis and musculoskeletal pain patients, not menopausal women specifically, but the conditions are among the most common complaints during and after the transition.
A 2019 meta-analysis published in BMJ Open analyzed 22 placebo-controlled trials (n=1,063) of low-level laser therapy for knee osteoarthritis. The review found statistically significant pain reduction compared to placebo.
A 2022 review confirmed that PBM significantly reduces pain across multiple musculoskeletal conditions including knee, neck, shoulder, and back pain. A separate pooled analysis by Clijsen and colleagues reached similar conclusions. A 2019 meta-analysis of PBM for fibromyalgia found significant improvements in pain, fatigue, and quality of life, relevant because fibromyalgia and menopause share overlapping symptom profiles.
For targeted research on one of the most common pain sites, see our review of red light therapy for knee pain.
Sleep
Sleep disruption during menopause is driven by more than night sweats. Melatonin production declines with age, and the hormonal shifts of menopause further alter the sleep signaling pathway.
The direct evidence comes from a study from Zhao and colleagues (2012) who tested red light therapy (30 minutes nightly for 14 nights) in 20 female Chinese basketball players (mean age 18.6 years) [10]. Sleep quality improved significantly (P < .001 between groups), and melatonin levels rose significantly (P < .01).
Skin Health
When estrogen levels decline after menopause, the cells that produce collagen become less active, resulting in thinner skin, deeper wrinkles, and slower healing. A peer-reviewed analysis in Seminars in Cutaneous Medicine and Surgery confirmed beneficial outcomes for PBM across wrinkle reduction, scar repair, and tissue quality in aging skin, with documented collagen stimulation [8]. This examined skin aging generally, not menopause-specific changes, but the mechanism (stimulating collagen-producing cells) applies regardless of whether skin thinning is driven by chronological aging or estrogen loss.
Pelvic Tissue Health
Genitourinary syndrome of menopause (GSM), the thinning, dryness, and inflammation of vaginal and urinary tract tissues caused by estrogen loss, is widely undertreated.
A 2019 narrative review published in Photobiomodulation, Photomedicine, and Laser Surgery concluded that "based on the preliminary evidence available, PBMT is safe and appears to be efficacious in treating GSM".
Conclusion
Red light therapy for menopause has strong evidence for joint pain and early but promising evidence for sleep, skin, and pelvic health.— William Carter, MD
For women managing multiple symptoms at once (as most do), a therapy that addresses them through shared cellular mechanisms offers something qualitatively different from the isolated-symptom approach that conventional treatment typically delivers.
Red light therapy for menopause has strong evidence for joint pain and early but promising evidence for sleep, skin, and pelvic health.
